Arriving in the arena of obesity therapy, retatrutide represents a unique approach. Unlike many current medications, retatrutide functions as a twin agonist, at once engaging both glucagon-like peptide-1 (GLP-1) and https://tiffanyqfac342901.answerblogs.com/39011412/this-innovative-retatrutide-a-glp-gip-binding-site-agonist